A Study of UFT+ Leucovorin (L) Given as a Three Times Daily (TID) Regimen in the Treatment of Patients (Pts) with Metastatic Breast Cancer (MBC)
Rivera E, Hyzinski M, Hutchins LF, Booser D, Mason B, Hortobagyi G. A Study of UFT+ Leucovorin (L) Given as a Three Times Daily (TID) Regimen in the Treatment of Patients (Pts) with Metastatic Breast Cancer (MBC). 2001.